Copyright
©2014 Baishideng Publishing Group Inc.
World J Cardiol. Jul 26, 2014; 6(7): 653-662
Published online Jul 26, 2014. doi: 10.4330/wjc.v6.i7.653
Published online Jul 26, 2014. doi: 10.4330/wjc.v6.i7.653
Experimental system | Monitored response | Ref. |
Cultured cardiomyocytes | ||
NRG-1 administration | Prevented myofibril disarray | [55] |
Attenuated troponin degradation | [56] | |
Animal models | ||
NRG1-deficiency/doxorubicin (NRG1 heterozygous mouse) | Induced heart failure | [57] |
NRG1-deficiency/doxorubicin (Ventricular specific-erbB4-KO) | Deregulated Protein Homeostasis Autophagic vacuolization | [58] |
- Citation: Vasti C, Hertig CM. Neuregulin-1/erbB activities with focus on the susceptibility of the heart to anthracyclines. World J Cardiol 2014; 6(7): 653-662
- URL: https://www.wjgnet.com/1949-8462/full/v6/i7/653.htm
- DOI: https://dx.doi.org/10.4330/wjc.v6.i7.653